Inventor · disambiguated record
Robert Zhiyong Luo
Also filed as: LUO ROBERT · LUO ROBERT Z · LUO ROBERT ZHIYONG
18 granted patents·15 pending applications·136 citations·filing 2000–2024
93Inventor score
Files withACCUTAR BIOTECHNOLOGY INC7CARA THERAPEUTICS INC7CHROMOCELL CORP7TIGER BIOTHERAPEUTICS INC4LUO ROBERT ZHIYONG2
Top patents by PatentIndex Score
33 records- 0197US8217007B1Synthetic peptide amidesSCHTEINGART CLAUDIO D·Filed 2010·Granted Jul 10, 2012·64 cites·20 claims
- 0295US7741350B1Bicyclic pyrazolo-heterocyclesCARA THERAPEUTICS INC·Filed 2009·Granted Jun 22, 2010·22 cites·19 claims
- 0393US8906859B2Uses of kappa opioid synthetic peptide amidesSCHTEINGART CLAUDIO D·Filed 2010·Granted Dec 9, 2014·12 cites·23 claims
- 0492US9321810B2Uses of kappa opioid synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2014·Granted Apr 26, 2016·8 cites·20 claims
- 0591US9359399B2Synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2014·Granted Jun 7, 2016·10 cites·20 claims
- 0690US10138270B2Synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2016·Granted Nov 27, 2018·6 cites·15 claims
- 0784US10793596B2Synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2018·Granted Oct 6, 2020·2 cites·18 claims
- 0882US9458118B2Sodium channel modulators for the treatment of pain and diabetesCHROMOCELL CORP·Filed 2016·Granted Oct 4, 2016·3 cites·18 claims
- 0979US12195459B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2024·Granted Jan 14, 2025·0 cites·46 claims
- 1079US12110291B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 8, 2024·0 cites·32 claims
- 1177US8653127B2Bicyclic pyrazolo-heterocyclesLUO ROBERT ZHIYONG·Filed 2010·Granted Feb 18, 2014·5 cites·17 claims
- 1277US2025092039A1Glutarimide-containing pan-kras-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1376US8211926B2Bicyclic pyrazolo-heterocyclesLUO ROBERT ZHIYONG·Filed 2010·Granted Jul 3, 2012·2 cites·15 claims
- 1471US2015050410A1Compounds, compositions, and methods for modulating sweet tasteCHROMOCELL CORP·Filed 2014·Application pending·0 cites
- 1570US12168058B2Glutarimide-containing KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2023·Granted Dec 17, 2024·0 cites·47 claims
- 1668US8835422B2Substituted imidazoheterocycle derivativesO'CONNOR STEPHEN J·Filed 2009·Granted Sep 16, 2014·1 cites·9 claims
- 1765US2024208909A1Substituted quinoline derivatives having sos1 inhibition activities and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 1865US2024190842A1Substituted quinolinone-8-carbonitrile derivatives having androgen degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 1965US2025002473A1Quinoxaline derived sulfonamides with egfr degradation activities and their uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 2063US2016015064A1Compounds, compositions, and methods for modulating sweet tasteCHROMOCELL CORP·Filed 2014·Application pending·0 cites
- 2161US11530222B2Substituted pyrrolopyrimidine and pyrazolopyrimidine as Bruton's tyrosine kinase (BTK) degradersACCUTAR BIOTECHNOLOGY INC·Filed 2022·Granted Dec 20, 2022·0 cites·30 claims
- 2261US10179781B2Sodium channel modulators for the treatment of painCHROMOCELL CORP·Filed 2014·Granted Jan 15, 2019·1 cites·22 claims
- 2359US2024398805A1Quinazoline derived compounds as egfr inhibitors and their uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 2459US2016310558A1Uses of kappa opioid synthetic peptide amidesCARA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2559US2024051940A1Sulfonamides with egfr inhibition activities and their use thereofACCUTAR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 2657US2022112204A1Substituted dihydropyranopyrimidine compounds as kras inhibitorsACCUTAR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2755US8431565B2Substituted imidazoheterocyclesBECKETT R PAUL·Filed 2008·Granted Apr 30, 2013·0 cites·22 claims
- 2854US2016221974A1Sodium channel modulators for the treatment of pain and diabetesCHROMOCELL CORP·Filed 2014·Application pending·0 cites
- 2953US2011190336A1AzabenzimidazolonesCARA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3051US2021338557A1Oxidized Derivatives of GDF-11 FragmentsAVON PROD INC·Filed 2019·Application pending·0 cites
- 3145US2017303574A1Compounds, compositions, and methods for modulating sweet tasteCHROMOCELL CORP·Filed 2015·Application pending·0 cites
- 3234US2017304306A1SELECTIVE NaV1.7 INHIBITORS FOR THE TREATMENT OF DIABETESCHROMOCELL CORP·Filed 2015·Application pending·0 cites
- 3321US7181349B1Identification of compounds for modulating dimeric receptorsYIP CECIL·Filed 2000·Granted Feb 20, 2007·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Robert Zhiyong Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →